← Back to headlines
J&J's Darzalex Receives Approval for First Self-Administered Cancer Injectable
Johnson & Johnson's Darzalex has secured approval for its self-administered injectable formulation, marking a significant milestone as the first of its kind for cancer treatment.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
West Nile Fever Cases and Fatalities Reported in Serbia and North Macedonia
49m ago
Five Teenagers Die in Ireland Driving Wrong Way on Motorway for Social Media Trend
49m ago
Metro Manila Inundated by Heavy Monsoon Rains
2h ago
Hayden Panettiere's Life and Career Remembered Amidst Personal Struggles
3h ago